Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Here is What Hedge Funds Think About Ciena Corporation (CIEN)

Page 1 of 2

Is Ciena Corporation (NASDAQ:CIEN) a good investment?

In the financial world, there are many methods investors can use to monitor publicly traded companies. A pair of the best are hedge fund and insider trading movement. At Insider Monkey, our research analyses have shown that, historically, those who follow the best picks of the elite fund managers can trounce the broader indices by a healthy margin (see just how much).

Just as key, positive insider trading sentiment is another way to look at the investments you’re interested in. Obviously, there are plenty of reasons for an insider to cut shares of his or her company, but only one, very obvious reason why they would behave bullishly. Several empirical studies have demonstrated the valuable potential of this tactic if you know where to look (learn more here).

What’s more, we’re going to analyze the recent info about Ciena Corporation (NASDAQ:CIEN).

What have hedge funds been doing with Ciena Corporation (NASDAQ:CIEN)?

Heading into Q3, a total of 23 of the hedge funds we track were long in this stock, a change of -15% from one quarter earlier. With hedge funds’ capital changing hands, there exists a few notable hedge fund managers who were boosting their holdings considerably.

Ciena Corporation (NASDAQ:CIEN)According to our 13F database, Kerr Neilson’s Platinum Asset Management had the most valuable position in Ciena Corporation (NASDAQ:CIEN), worth close to $129.9 million, accounting for 2.5% of its total 13F portfolio. The second largest stake is held by Ken Griffin of Citadel Investment Group, with a $53.5 million position; 0.1% of its 13F portfolio is allocated to the stock. Remaining hedge funds that hold long positions include Christopher Zepf and Brian Thonn’s Kingdom Ridge Capital, John Murphy’s Alydar Capital and Jim Simons’s Renaissance Technologies.

Because Ciena Corporation (NASDAQ:CIEN) has faced declining interest from the smart money’s best and brightest, it’s safe to say that there was a specific group of hedgies that decided to sell off their entire stakes heading into Q2. At the top of the heap, Mariko Gordon’s Daruma Asset Management sold off the largest stake of all the hedgies we monitor, comprising an estimated $41.3 million in stock, and Charles Clough of Clough Capital Partners was right behind this move, as the fund dumped about $9.4 million worth. These transactions are interesting, as total hedge fund interest dropped by 4 funds heading into Q2.

What do corporate executives and insiders think about Ciena Corporation (NASDAQ:CIEN)?

Bullish insider trading is particularly usable when the primary stock in question has experienced transactions within the past 180 days. Over the latest six-month time frame, Ciena Corporation (NASDAQ:CIEN) has experienced zero unique insiders purchasing, and zero insider sales (see the details of insider trades here).

We’ll also examine the relationship between both of these indicators in other stocks similar to Ciena Corporation (NASDAQ:CIEN). These stocks are NetGear, Inc. (NASDAQ:NTGR), Exelis Inc (NYSE:XLS), Acme Packet, Inc. (NASDAQ:APKT), Loral Space & Communications Ltd. (NASDAQ:LORL), and Arris Group, Inc. (NASDAQ:ARRS). This group of stocks are the members of the communication equipment industry and their market caps match CIEN’s market cap.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!